BrainsWay Reports Positive Pilot Study Results For Deep TMS In Depression & Early Alzheimer's

BrainsWay reported a peer-reviewed pilot study evaluating its Deep TMS technology in patients with major depressive disorder and comorbid early-stage Alzheimer's disease. The article did not disclose efficacy, safety, or financial results, limiting the immediate valuation impact, but the study supports ongoing clinical validation of the company's neurostimulation platform.